GO:0061702 canonical inflammasome complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061702 (canonical inflammasome complex) is a cytosolic protein complex that activates caspase-1.
• The canonical inflammasome is a macromolecular platform that drives inflammation through caspase-1 activation and pyroptosis.
• Key components include NLRP3, NLRC4, AIM2, and NLRP1, which sense distinct danger signals and assemble with ASC and pro-caspase-1.
• Gasdermin D is a downstream effector of canonical inflammasome activation, mediating pyroptosis and IL-1beta release.
• Dysregulated canonical inflammasome activity is implicated in inflammatory diseases, cancer, and neurodegeneration.
• CRISPR-based models (knockout, knock-in, point mutation, overexpression) are essential for dissecting canonical inflammasome gene function.
Description
The canonical inflammasome complex (GO:0061702) is a cytosolic protein complex that is capable of activating caspase-1. It serves as a central signaling hub of innate immunity, assembling in response to pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). This complex is termed canonical to distinguish it from non-canonical inflammasomes, which activate caspase-11 in mice or caspase-4/5 in humans. The canonical inflammasome is a macromolecular machine that nucleates around sensor proteins such as NLRP3, NLRC4, AIM2, or NLRP1, and typically recruits the adaptor ASC and pro-caspase-1. Its formation leads to caspase-1 activation, which in turn cleaves pro-IL-1beta and pro-IL-18 into their active forms and cleaves gasdermin D to induce pyroptosis. Researchers study GO:0061702 to understand inflammatory signaling, host defense, and the pathogenesis of numerous diseases, including autoinflammatory disorders, cancer, and neurodegenerative conditions.
canonical inflammasome complex At A Glance
| GO ID | GO:0061702 |
|---|---|
| GO term | canonical inflammasome complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Activates caspase-1 in the cytosol, leading to inflammatory cytokine maturation and pyroptosis. |
| Key components | Sensor proteins (e.g., NLRP3, NLRC4, AIM2, NLRP1), adaptor ASC, and pro-caspase-1. |
| Cellular location | Cytosol. |
| Associated processes | Inflammation, pyroptosis, innate immune response. |
What Is GO:0061702?
According to the Gene Ontology, GO:0061702 (canonical inflammasome complex) is defined as a cytosolic protein complex that is capable of activating caspase-1. This definition captures the essential function of the complex: it serves as a platform for caspase-1 activation within the cytoplasm, leading to downstream inflammatory responses.
Why Is canonical inflammasome complex Important in Cell Biology?
The canonical inflammasome complex is critically important because it orchestrates a primary innate immune response to infection and tissue damage. Its activation triggers caspase-1, which matures interleukin-1beta and interleukin-18 and cleaves gasdermin D to induce pyroptosis, a lytic form of cell death that releases inflammatory contents. This process is essential for host defense but can also cause pathology when dysregulated, contributing to a wide range of inflammatory and autoimmune diseases, as well as influencing cancer progression and neurodegeneration. Understanding GO:0061702 is therefore fundamental for immunology research and for developing therapeutics targeting inflammasome-driven diseases.
• Central to innate immunity and host defense against pathogens.
• Drives maturation of pro-inflammatory cytokines IL-1beta and IL-18.
• Induces pyroptosis via gasdermin D cleavage, a key inflammatory cell death pathway.
• Implicated in autoinflammatory diseases such as cryopyrin-associated periodic syndromes.
• Contributes to the pathogenesis of atherosclerosis, type 2 diabetes, and gout.
• Plays complex roles in cancer, with both pro- and anti-tumor effects depending on context.
• Involved in neuroinflammation and neurodegenerative diseases like Alzheimer's.
• Target for small-molecule inhibitors such as MCC950, highlighting therapeutic potential.
• Provides a model system for studying macromolecular complex assembly and signaling.
• Essential for understanding inflammatory mechanisms in alveolar bone loss and periodontitis.
What Happens During canonical inflammasome complex?
Priming and Sensor Activation
In simple terms: First, the cell gets ready by increasing inflammasome components, then a danger signal triggers a sensor protein.
Canonical inflammasome activation typically requires a priming step, often mediated by NF-kB signaling, which upregulates sensor proteins like NLRP3 and pro-IL-1beta. Subsequently, a second signal, such as ATP, nigericin, or crystalline substances, induces sensor activation. For NLRP3, this involves potassium efflux, lysosomal damage, or mitochondrial dysfunction. Other sensors like NLRC4 detect bacterial flagellin, AIM2 binds cytosolic DNA, and NLRP1 responds to specific proteases. This sensor activation is the initial step in assembling the canonical inflammasome complex.
Nucleation and Assembly
In simple terms: The activated sensor protein starts to gather other proteins to form a large complex.
Upon activation, sensor proteins undergo conformational changes that allow them to nucleate the assembly of the inflammasome complex. For NLRP3 and AIM2, this involves recruitment of the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) via pyrin domain interactions. ASC then polymerizes into filaments, forming a speck that serves as a platform for pro-caspase-1 recruitment. NLRC4 can directly recruit pro-caspase-1 through CARD-CARD interactions, but ASC enhances its activity. The assembly process is highly regulated and represents a key checkpoint in canonical inflammasome function.
Caspase-1 Activation
In simple terms: The assembled complex activates caspase-1, which then cuts other proteins to cause inflammation.
Once assembled, the canonical inflammasome complex activates pro-caspase-1 through proximity-induced autoproteolysis. Active caspase-1 is a cysteine protease that cleaves specific substrates, including pro-IL-1beta and pro-IL-18, into their mature, secreted forms. Caspase-1 also cleaves gasdermin D, releasing its N-terminal fragment that forms pores in the plasma membrane, leading to pyroptosis. This activation step is the defining feature of the canonical inflammasome complex, as per its GO definition.
Downstream Inflammatory Responses
In simple terms: The active caspase-1 causes release of inflammatory cytokines and a form of cell death called pyroptosis.
Active caspase-1 mediates the maturation and secretion of IL-1beta and IL-18, which are potent pro-inflammatory cytokines. Additionally, gasdermin D cleavage induces pyroptosis, a lytic cell death that releases cellular contents and amplifies inflammation. Pyroptosis is distinct from apoptosis and is a key effector mechanism of canonical inflammasome signaling. These downstream events contribute to pathogen clearance but can also cause tissue damage in inflammatory diseases.
Key Genes Involved in GO:0061702 canonical inflammasome complex
The following genes encode core components and regulators of the canonical inflammasome complex, and are frequently studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Sensor protein that detects diverse danger signals and nucleates inflammasome assembly. | Most studied inflammasome sensor; target for inflammatory disease therapeutics. |
| NLRC4 | Sensor for bacterial flagellin and T3SS components; activates caspase-1. | Key in antibacterial defense and autoinflammatory syndromes. |
| AIM2 | Cytosolic DNA sensor; forms inflammasome upon binding dsDNA. | Important in host defense against DNA viruses and in autoimmunity. |
| NLRP1 | Sensor activated by proteolytic cleavage; forms inflammasome in response to certain toxins. | Implicated in skin inflammation and cancer. |
| PYCARD (ASC) | Adaptor protein linking sensors to pro-caspase-1; forms specks. | Central hub; knockout abolishes many inflammasome responses. |
| CASP1 | Pro-caspase-1 is recruited and activated by the inflammasome; cleaves IL-1beta, IL-18, and gasdermin D. | Effector of canonical inflammasome; target for functional studies. |
| GSDMD | Gasdermin D is cleaved by caspase-1 to induce pyroptosis. | Key executioner of pyroptosis; knockout blocks cell death. |
| IL1B | Pro-IL-1beta is cleaved by caspase-1 to mature IL-1beta. | Major inflammatory cytokine; readout of inflammasome activation. |
| IL18 | Pro-IL-18 is cleaved by caspase-1 to mature IL-18. | Inflammatory cytokine; involved in Th1 responses. |
| NEK7 | Kinase required for NLRP3 inflammasome assembly. | Regulator of NLRP3 activation; knockout impairs IL-1beta release. |
| TXNIP | Thioredoxin-interacting protein links oxidative stress to NLRP3 activation. | Modulates inflammasome in metabolic stress. |
| CARD8 | Sensor forming inflammasome in response to DPP9 inhibition. | Emerging inflammasome sensor; less studied. |
| NLRP6 | Sensor involved in intestinal homeostasis and inflammasome formation. | Enigmatic inflammasome; role in microbiota regulation. |
| NLRP12 | Sensor with regulatory roles in inflammation. | Enigmatic inflammasome; may inhibit NF-kB. |
| IFI16 | Nuclear DNA sensor that can form inflammasome. | Enigmatic inflammasome; involved in viral sensing. |
| MEFV (Pyrin) | Sensor for RhoA inactivation; forms inflammasome. | Mutations cause familial Mediterranean fever. |
How Is canonical inflammasome complex Regulated?
Canonical inflammasome complex activity is tightly regulated at multiple levels to prevent excessive inflammation. Priming signals, such as TLR agonists, upregulate NLRP3 and pro-IL-1beta via NF-kB. Post-translational modifications, including phosphorylation and ubiquitination, modulate sensor activity. Autophagy and mitophagy can remove damaged mitochondria, limiting NLRP3 activation. Small molecules like MCC950 specifically inhibit NLRP3, demonstrating pharmacological control. Additionally, regulatory proteins such as pyrin-only proteins (POPs) and CARD-only proteins (COPs) can interfere with inflammasome assembly. Dysregulation of these control mechanisms contributes to inflammatory diseases.
canonical inflammasome complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Cryopyrin-associated periodic syndromes (CAPS), gout, atherosclerosis | NLRP3 knockout or point-mutation knock-in mice or cell lines |
| MEFV | Familial Mediterranean fever | MEFV knock-in mice carrying patient mutations |
| NLRC4 | Autoinflammatory syndrome with macrophage activation | NLRC4 knockout and transgenic overexpression models |
| GSDMD | Pyroptosis-related inflammatory diseases | GSDMD knockout cells to assess pyroptosis |
| IL1B | Autoinflammatory and autoimmune conditions | IL1B knockout or reporter knock-in for cytokine tracking |
Inflammatory and Autoimmune Diseases
Hyperactivation of the canonical inflammasome complex is a driver of numerous inflammatory disorders. Gain-of-function mutations in NLRP3 cause cryopyrin-associated periodic syndromes (CAPS), which are alleviated by IL-1 blockade. The NLRP3 inflammasome also contributes to gout, atherosclerosis, and type 2 diabetes through IL-1beta-mediated inflammation. In periodontal disease, inflammasome activation is linked to alveolar bone loss. These examples highlight the canonical inflammasome as a therapeutic target.
Cancer
The role of the canonical inflammasome in cancer is context-dependent. In some models, inflammasome-driven IL-1beta promotes tumorigenesis and metastasis, while in others it enhances anti-tumor immunity. Pyroptosis of tumor cells can release immunogenic signals, but chronic inflammation may also promote cancer. Understanding the dual roles requires further research using knockout and knock-in models.
Neurodegenerative Diseases
Neuroinflammation mediated by the NLRP3 inflammasome is implicated in Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Amyloid-beta and alpha-synuclein can activate NLRP3, leading to IL-1beta release and neuronal damage. Inhibiting the inflammasome is being explored as a neuroprotective strategy.
From canonical inflammasome complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate canonical inflammasome assembly? | Knockout cell line (e.g., NLRP3 KO) followed by inflammasome activation assays |
| Does a specific mutation in NLRP3 affect inflammasome activity? | Point-mutation knock-in (e.g., NLRP3 A350V) in cell lines or mice |
| Can we track inflammasome speck formation in live cells? | Tagged knock-in of ASC or caspase-1 with fluorescent protein |
| Does overexpression of a sensor enhance inflammasome response? | Overexpression of NLRP3 or AIM2 in HEK293T or THP-1 cells |
| What is the role of a candidate gene in IL-1beta release? | CRISPR knockout followed by ELISA for IL-1beta |
| Can we identify novel inflammasome regulators? | Genome-wide CRISPR library screening with pyroptosis readout |
How to Study the canonical inflammasome complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Cleavage of caspase-1, gasdermin D, IL-1beta | Confirming inflammasome activation in cell lysates |
| ELISA | Secreted IL-1beta and IL-18 | Quantifying cytokine release in supernatants |
| ASC speck imaging | Assembly of ASC specks | Visualizing inflammasome nucleation |
| FLICA assay | Active caspase-1 | Flow cytometric detection of inflammasome activation |
| LDH release assay | Pyroptosis-mediated membrane damage | Measuring cell death in response to inflammasome triggers |
| CRISPR knockout | Gene requirement for inflammasome function | Loss-of-function studies in cell lines |
| CRISPR knock-in | Effect of specific mutations | Modeling disease-associated variants |
| RNA-seq | Transcriptional changes upon activation | Identifying inflammasome-regulated genes |
Biochemical Assays for Inflammasome Activation
Inflammasome activation is commonly measured by detecting caspase-1 cleavage, IL-1beta secretion, and gasdermin D cleavage using Western blotting and ELISA. ASC speck formation can be visualized by immunofluorescence or by using fluorescently tagged ASC. These methods provide direct readouts of canonical inflammasome complex function.
Genetic Approaches: Knockout and Knock-in
CRISPR-Cas9 knockout of inflammasome genes (e.g., NLRP3, CASP1, GSDMD) is widely used to assess their requirement for inflammasome responses. Knock-in of point mutations (e.g., disease-associated NLRP3 variants) allows study of specific residues in inflammasome activation. These genetic models are essential for causal inference.
Imaging and Flow Cytometry
Fluorescence microscopy can visualize ASC specks and gasdermin D pores. Flow cytometry is used to measure caspase-1 activity with fluorescent inhibitors (FLICA) and to detect pyroptosis by membrane permeability dyes. These techniques enable single-cell analysis of inflammasome activation.
Omics and CRISPR Screening
Transcriptomic and proteomic analyses can reveal global changes upon inflammasome activation. Genome-wide CRISPR screens have identified novel regulators of pyroptosis and inflammasome function. These unbiased approaches accelerate discovery in the field.
How CRISPR Can Be Used to Study GO:0061702 canonical inflammasome complex
Knockout
CRISPR knockout of canonical inflammasome genes such as NLRP3, CASP1, or GSDMD is a standard approach to determine their essential roles. For example, NLRP3 knockout cells fail to release IL-1beta in response to nigericin, confirming its requirement. Knockout models are also used to dissect redundancy among sensors.
Point Mutation
Point mutations identified in patients (e.g., NLRP3 A350V) can be introduced via CRISPR knock-in to study their impact on inflammasome assembly and activity. Such models help establish causality of specific variants in autoinflammatory diseases.
Knock-in
Knock-in of tagged proteins (e.g., GFP-ASC) allows real-time visualization of inflammasome specks. Knock-in of reporter genes (e.g., IL-1beta-luciferase) enables high-throughput screening. These models are valuable for dynamic studies.
Overexpression
Overexpression of inflammasome components (e.g., NLRP3, AIM2) in cell lines like HEK293T can reconstitute inflammasome activation and facilitate structure-function studies. However, overexpression may cause artifacts, so results should be validated at endogenous levels.
How EDITGENE Supports canonical inflammasome complex Research
Researchers studying canonical inflammasome complex-related genes often need to determine whether a candidate gene is causally involved in inflammasome activation, cytokine release, or pyroptosis. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of inflammasome components and regulators.
Contact EDITGENE today to design your custom CRISPR model for canonical inflammasome complex research.
Frequently Asked Questions About canonical inflammasome complex
What is the canonical inflammasome complex?
The canonical inflammasome complex (GO:0061702) is a cytosolic protein complex that activates caspase-1, leading to inflammatory cytokine maturation and pyroptosis.
What genes are involved in the canonical inflammasome complex?
Key genes include NLRP3, NLRC4, AIM2, NLRP1, PYCARD (ASC), CASP1, and GSDMD, among others.
How is the canonical inflammasome activated?
It is activated by pathogen- or danger-associated molecular patterns that trigger sensor proteins like NLRP3 or AIM2, leading to complex assembly and caspase-1 activation.
What is the difference between canonical and non-canonical inflammasomes?
Canonical inflammasomes activate caspase-1, while non-canonical inflammasomes activate caspase-11 in mice or caspase-4/5 in humans.
What diseases are associated with the canonical inflammasome?
Dysregulated canonical inflammasome activity is linked to cryopyrin-associated periodic syndromes, gout, atherosclerosis, cancer, and neurodegenerative diseases.
How can I study the canonical inflammasome in the lab?
Common methods include Western blot for caspase-1 and gasdermin D cleavage, ELISA for IL-1beta, ASC speck imaging, and CRISPR knockout models.
What is the role of gasdermin D in the canonical inflammasome?
Gasdermin D is cleaved by caspase-1 to form membrane pores, leading to pyroptosis and release of inflammatory cytokines.
Can CRISPR be used to study inflammasome genes?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in inflammasome biology.
What is an ASC speck?
ASC specks are large aggregates of the adaptor protein ASC that form upon inflammasome assembly and serve as platforms for caspase-1 activation.
Are there inhibitors of the canonical inflammasome?
Yes, MCC950 is a small-molecule inhibitor of the NLRP3 inflammasome that has shown efficacy in preclinical models of inflammatory diseases.
Conclusion
The canonical inflammasome complex (GO:0061702) is a fundamental component of innate immunity, driving caspase-1 activation, cytokine maturation, and pyroptosis. Its dysregulation contributes to a broad spectrum of human diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based gene editing and screening technologies are accelerating our understanding of inflammasome assembly and regulation. EDITGENE's comprehensive services empower researchers to generate precise models and uncover new insights into canonical inflammasome biology.
References
- 1. Monie TP. 2017. The Canonical Inflammasome: A Macromolecular Complex Driving Inflammation.. Subcell Biochem 83:43-73 PMID: 28271472
- 2. Triantafilou K. 2021. Enigmatic inflammasomes.. Immunology 162(3):249-251 PMID: 33590488
- 3. Fu J et al.. 2024. Mechanistic insights from inflammasome structures.. Nat Rev Immunol 24(7):518-535 PMID: 38374299
- 4. Burdette BE et al.. 2021. Gasdermin D in pyroptosis.. Acta Pharm Sin B 11(9):2768-2782 PMID: 34589396
- 5. Li Y et al.. 2021. Inflammasomes in Alveolar Bone Loss.. Front Immunol 12:691013 PMID: 34177950
- 6. Coll RC et al.. 2015. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.. Nat Med 21(3):248-55 PMID: 25686105
- 7. Liu Y et al.. 2024. Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.. Signal Transduct Target Ther 9(1):245 PMID: 39300122
- 8. Wang C et al.. 2021. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation.. Sci Immunol 6(64):eabj3859 PMID: 34678046
